Phathom Pharmaceuticals, Inc.

PHAT · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets
Cash & Equivalents$297,263$381,393$155,385$183,259
Short-Term Investments$0$0$0$0
Receivables$38,797$1,637$0$0
Inventory$3,208$1,208$0$0
Other Curr. Assets$20,866$13,194$5,127$3,267
Total Curr. Assets$360,134$397,432$160,512$186,526
Property Plant & Equip (Net)$2,089$3,621$3,494$2,564
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$2,862$0$505$0
Tax Assets$0$0$0$0
Other NC Assets$13,233$12,789$299$341
Total NC Assets$18,184$16,410$4,298$2,905
Other Assets$0$0$0$0
Total Assets$378,318$413,842$164,810$189,431
Liabilities
Payables$10,507$12,601$9,997$5,150
Short-Term Debt$20,278$726$708$487
Tax Payable$0$0$0$0
Deferred Revenue$0$0$0$0
Other Curr. Liab.$54,943$25,454$15,532$13,284
Total Curr. Liab.$85,728$38,781$26,237$18,921
LT Debt$534,670$138,304$96,362$90,854
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$11,500$309,516$117,025$7,500
Total NC Liab.$546,170$447,820$213,387$98,354
Other Liabilities$0$0$0$0
Cap. Leases$501$1,188$1,806$1,670
Total Liabilities$631,898$486,601$239,624$117,275
Equity
Pref Stock$0$0$0$0
Common Stock$6$5$3$3
Retained Earnings-$1,263,011-$928,685-$727,093-$529,370
AOCI$0$0$0$0
Other Equity$1,009,425$855,921$652,276$601,523
Total Equity-$253,580-$72,759-$74,814$72,156
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$378,318$413,842$164,810$189,431
Net Debt$257,685-$242,363-$58,315-$91,918
Phathom Pharmaceuticals, Inc. (PHAT) Financial Statements & Key Stats | AlphaPilot